Literature DB >> 8411436

Corticosteroid-associated fatal mycobacterial sepsis occurring 3 years after instillation of intravesical bacillus Calmette-Guerin.

J K Izes1, W Bihrle, C B Thomas.   

Abstract

A case is reported of systemic Mycobacterium bovis infection that occurred 3 years after uneventful instillation of intravesical bacillus Calmette-Guerin (BCG) and after several months of oral prednisone therapy. The literature on delayed BCG infection and the systemic persistence of BCG after intravesical instillation is reviewed. We propose that rarely a reservoir of dormant M. bovis may become established after intravesical therapy. Reactivation infection may later develop in a manner that parallels the natural history of secondary tuberculosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8411436     DOI: 10.1016/s0022-5347(17)35824-x

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

1.  [Dyspnea after instillation therapy for bladder cancer].

Authors:  D Julius; H F Geerdes Fenge; M-A Weber
Journal:  Radiologe       Date:  2018-05       Impact factor: 0.635

Review 2.  Left Anterior Descending Coronary Artery and Multiple Peripheral Mycotic Aneurysms Due to Mycobacterium Bovis Following Intravesical Bacillus Calmette-Guerin Therapy: A Case Report.

Authors:  Petar Duvnjak; Mario Laguna
Journal:  J Radiol Case Rep       Date:  2016-08-31

3.  A cough conundrum in a patient with a previous history of BCG immunotherapy for bladder cancer.

Authors:  Arpan R Mehta; Puja R Mehta; Rajesh L Mehta
Journal:  BMJ Case Rep       Date:  2012-10-24

4.  Subclinical miliary Mycobacterium bovis following BCG immunotherapy for transitional cell carcinoma of the bladder.

Authors:  Chang-Ho Ryan Choi; Sang Oh Lee; Geoff Smith
Journal:  BMJ Case Rep       Date:  2014-05-08

5.  Combined infection of vertebroplasty and aortic graft after intravesical BCG treatment.

Authors:  Bart Santbergen; P H W E Vriens; W C M de Lange; M E E Van Kasteren
Journal:  BMJ Case Rep       Date:  2013-01-25

Review 6.  Current recommendations for bladder instillation therapy in the treatment of interstitial cystitis/bladder pain syndrome.

Authors:  Marc A Colaco; Robert J Evans
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

Review 7.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

Review 8.  Mycobacterium bovis-induced Aneurysm after Intravesical Bacillus Calmette-Guérin Therapy: A Case Study and Literature Review.

Authors:  Yoshitsugu Higashi; Shigeki Nakamura; Kento Kidani; Kaoru Matumoto; Koyomi Kawago; Junko Isobe; Junichi Kanatani; Yukio Kawagishi; Ippei Sakamaki; Yoshihiro Yamamoto
Journal:  Intern Med       Date:  2017-11-01       Impact factor: 1.271

9.  Infection of an axillo-bifemoral bypass graft following intravesical bacillus Calmette-Guerin (BCG) immunotherapy for urothelial cancer due to Mycobacterium bovis and Staphylococcus aureus.

Authors:  Daniel C DeSimone; Aaron J Tande
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2016-09-16

10.  Mycobacterium bovis Osteomyelitis of the Thoracic Spine Mimicking a Metastatic Lytic Lesion in a Patient Exposed to Intravesicular Bacille Calmette-Guérin Treatment.

Authors:  Jessica R Newman; Lisa A Clough; Fernando Merino
Journal:  Urol Case Rep       Date:  2014-07-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.